Arno Therapeutics, Inc.
Industry
- Pharmaceuticals
Latest on Arno Therapeutics, Inc.
GE Healthcare and Vanderbilt University Medical Center are working together to combine immuno-oncology with precision medicine through a five-year collaboration unveiled Jan. 6, to determine which
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in
Oncobiologics Inc. has appointed Lawrence Kenyon as its chief financial officer. Kenyon's most recent positions were at Arno Therapeutics Inc. (chief operating officer and CFO) and Tamir Biotechnology
Company Changes New At The Helm This Month AGARWAL , Sunil, MD To: Ultragenyx Pharmaceutical Inc. , SVP, CMO (August) From: Genentech Inc., SVP, Global Head, Clinical Dev., Immunology & Infectio